AskNiveshClosed·18:43 IST
  • Stocks
  • ·
  • Funds
  • ·
  • Signals

AskNivesh is a research desk for Indian markets, US equities, fund data, and disclosure trails. Built for investors who want source-backed context without the noise.

Market

  • Overview
  • Stocks
  • Indexes
  • Sectors
  • ETFs
  • Funds
  • IPOs
  • Earnings

US Market

  • Political Trades
  • Disclosure Leaderboard
  • Politicians
  • Consensus Trades
  • Late Disclosures
  • Sector Tilt
  • US Stocks

Market Pulse

  • Market Pulse
  • Global Markets
  • Currency Rates
  • Signals
  • FII DII Activity
  • Corporate Actions
  • RBI Macro
  • Derivatives
  • Currency Derivatives
  • Index Derivatives
  • Commodity Derivatives
  • F&O Expiries

Data

  • Glossary
  • Methodology
  • Analysis Methods
  • Technical Analysis
  • Candle Patterns
  • Brokers
  • Depositories
  • SEBI Intermediaries
  • Exchange Holidays
  • Global Investing
  • Sitemap

Company

  • About Us
  • Contact

Legal

  • Terms and Conditions
  • Privacy Policy
  • Disclaimer
  • Methodology
  • ·Glossary
  • ·Sitemap
  • ·Contact
Browse stocks by letter
AllABCDEFGHIJKLMNOPQRSTUVWXYZOthers

Research and education only. Not investment advice under SEBI (IA) Regulations 2013, not a research report under SEBI (RA) Regulations 2014. Not a SEBI-registered Adviser, Analyst, or distributor.

AskNivesh©2026
asknivesh.com
← Back to DRREDDY

Dr. Reddy's Laboratories Limited: Detailed financials

Line items extracted directly from the company's NSE-filed XBRL. Click + to expand subtotals. Click any row to chart it. All values in ₹ crore.

ParticularsSep-24Dec-24Mar-25Jun-25Sep-25Dec-25Mar-26Jun-26
Revenue
8,0388,3818,5288,5728,8288,7537,5468,100
Other income
308150522290324269475355
Segment revenue (incl. inter-segment)
8,0388,3818,5288,5728,8288,7537,5468,100
Expenses
6,4346,6617,0516,9587,4147,4817,8277,902
Cost of materials consumed
1,2871,4531,7162,0361,4411,8261,1991,654
Purchases of stock-in-trade
1,2831,0511,1281,2161,7461,5421,6581,974
Change in inventories
-203786-444-64-272356-242
Employee benefit expense
1,3991,3661,4011,5041,4521,5881,4471,652
Finance costs
768266839194106126
Depreciation & amortisation
397471455476505521557537
Other expenses
2,1962,1602,2802,0882,2432,1822,5042,203
EBITDA
2,3842,4232,5212,4642,3342,1568581,215
EBIT
1,9871,9522,0661,9881,8291,635301678
Operating profit
4,7774,9064,7274,8634,8144,6813,3693,755
Profit Before Tax
1,9111,8702,0001,9051,7381,541195552
Tax expense
576470418495408354-22118
Deferred tax
-196-63-14-5312231462-40
Net Profit
1,3421,4041,5871,4101,3371,190221436
Financial Ratios
Operating Profit Margin
59.43%58.54%55.43%56.73%54.53%53.48%44.65%46.36%
EBITDA Margin
29.66%28.91%29.56%28.74%26.44%24.64%11.37%15.00%
Net Profit Margin
16.70%16.75%18.61%16.45%15.14%13.60%2.93%5.38%
Earnings Per Share (₹)
15.0816.9719.1217.0416.1814.532.655.33

Revenue

₹ in crore

Click any row in the table to chart it here.

Source: NSE integrated filing results & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Ratios (operating margin, net margin) and EBITDA / EBIT / FCF / shareholders' funds are computed from the filed line items.